Clinical Care Intelligence Platform Abridge Raises $300 Million in Series E.

Led by Shiv Rao(CEO & Co-Founder), Zack Lipton(CTO), Julia Chou(COO), Brian Wilson(Chief Commercial Officer), Sagar Sanghvi(CFO), and Tim Hwang(General Counsel), Abridge has raised $300 Million in Series E led by Andreessen Horowitz, and joined by Khosla Ventures. The new capital will accelerate efforts to transform how care is delivered, documented, and reimbursed—beginning at the point of care.

Each year, the U.S. healthcare system spends nearly $1.5 trillion on administrative costs—much of it tied to clinical documentation and revenue cycle workflows that increasingly burden clinicians. These complex processes require capturing clinical details, translating them into evolving billing codes, and navigating payer requirements. The result: burnout, delays, and overhead.

To solve this, models have been trained in coding, risk adjustment, and utilization management—so that the right documentation is captured during care, not after. The new funding will help scale the platform to embed revenue cycle intelligence earlier and eliminate the need for manual follow-ups between clinicians and billing teams.

Abridge tackles clinical documentation—one of healthcare’s biggest pain points. Now used by 150+ major health systems across 55 specialties and 28 languages, it supports over 50 million medical conversations annually, reduces burnout by up to 70%, and retains over 90% of clinicians who start using it.